keyword
https://read.qxmd.com/read/38634099/the-burden-of-hypertension-related-chronic-kidney-disease-china-2010-2019
#1
JOURNAL ARTICLE
Youyuan Bu, Yueru Liu, Maigeng Zhou, Peng Yin, Kejun Liu, Yamin Bai, Xuancheng Lu
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: The global burden of chronic kidney disease (CKD) is on the rise. WHAT IS ADDED BY THIS REPORT?: In 2019, 5.58 million individuals in China were affected by CKD related to hypertension, leading to 70,260 fatalities and 1.69 million disability-adjusted life years (DALYs). The most affected groups were men, older individuals, and residents of western China. Over the period from 2010-2019, the age-standardized prevalence rate (ASPR) remained constant, and the age-standardized mortality rate (ASMR) and age-standardized DALY rate (ASDR) showed a decreasing trend...
April 5, 2024: China CDC weekly
https://read.qxmd.com/read/38623527/-quantification-of-the-burden-of-chronic-kidney-disease-in-latin-america-an-invisible-epidemicquantifica%C3%A3-%C3%A3-o-da-carga-da-doen%C3%A3-a-renal-cr%C3%A3-nica-na-am%C3%A3-rica-latina-uma-epidemia-invis%C3%A3-vel
#2
JOURNAL ARTICLE
Fernando Ulises Rosas-Valdez, Andrea Fernanda Aguirre-Vázquez, Marcela Agudelo-Botero
OBJECTIVE: 1) Describe the burden of chronic kidney disease in Latin American countries between 1990 and 2019; and 2) Estimate the correlation between disability-adjusted life years (DALYs) and the Sociodemographic Index and the Healthcare Access and Quality Index. METHODS: Secondary and ecological analysis, based on the 2019 Global Burden of Diseases, Injuries and Risk Factors Study. Standardized mortality rates, years of life lost to due to premature death (YLLs),years of healthy life lost due to disability (YLDs) and DALYs due to chronic kidney disease were reported for 1990, 2005, and 2019...
2024: Pan American Journal of Public Health
https://read.qxmd.com/read/38622232/unveiling-the-lead-exposure-attributed-burden-in-iran-from-1990-to-2019-through-the-lens-of-the-global-burden-of-disease-study-2019
#3
JOURNAL ARTICLE
Hanie Karimi, Sara Mahdavi, Sahar Saeedi Moghaddam, Mohsen Abbasi-Kangevari, Zahra Soleimani, Zahra Esfahani, Masoud Masinaei, Sahar Mohammadi Fateh, Ali Golestani, Arezou Dilmaghani-Marand, Farzad Kompani, Negar Rezaei, Erfan Ghasemi, Bagher Larijani, Farshad Farzadfar
This study aimed to investigate the estimated burden attributed to lead exposure (LE), at the national and subnational levels from 1990 to 2019 in Iran. The burden attributed to LE was determined through the estimation of deaths, disability-adjusted life years (DALYs), years of life lost (YLLs) and years lived with disability (YLDs) using the comparative risk assessment method of Global Burden of Disease (GBD) study presenting as age-standardized per 100,000 person year (PY) with 95% uncertainty intervals (95% UI)...
April 15, 2024: Scientific Reports
https://read.qxmd.com/read/38618500/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-latin-america-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#4
REVIEW
Viviane Calice-Silva, Javier A Neyra, Alejandro Ferreiro Fuentes, Krissia Kamile Singer Wallbach Massai, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Magdalena Madero, Carmen Tzanno Martins
Successful management of chronic kidney disease (CKD) in Latin America (LA) continues to represent a challenge due to high disease burden and geographic disparities and difficulties in terms of capacity, accessibility, equity, and quality of kidney failure care. Although LA has experienced significant social and economic progress over the past decades, there are still important inequities in health care access. Through this third iteration of the International Society of Nephrology Global Kidney Health Atlas, the indicators regarding kidney failure care in LA are updated...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38617006/the-characterization-and-comorbidities-of-heterozygous-bardet-biedl-syndrome-carriers
#5
JOURNAL ARTICLE
Meng-Hua Li, I-Chieh Chen, Hui-Wen Yang, Hsin-Chien Yen, Yung-Chieh Huang, Chia-Chi Hsu, Yi-Ming Chen, Yu-Yuan Ke
Introduction: Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder with clinical features of retinal dystrophy, obesity, postaxial polydactyly, renal anomalies, learning disabilities, hypogonadism, and genitourinary abnormalities. Nevertheless, previous studies on the phenotypic traits of BBS heterozygous carriers have generated inconclusive results. The aim of our study was to investigate the impact of BBS heterozygosity on carriers when compared to non-carriers within the Taiwanese population...
2024: International Journal of Medical Sciences
https://read.qxmd.com/read/38603531/high-need-beneficiary-enrollment-patterns-in-medicare-advantage-and-traditional-medicare
#6
JOURNAL ARTICLE
Aig Unuigbe, Inna Cintina, Julia Sheriff, Lane Koenig
OBJECTIVES: High-need Medicare beneficiaries require elevated levels of care and coordination to manage their conditions. We evaluated the extent to which high-need beneficiaries enrolled in Medicare Advantage (MA) or traditional Medicare (TM) accountable care organizations (ACOs) relative to TM non-ACOs. STUDY DESIGN: Using Medicare claims and MA encounter data, we identified 3 groups of high-need beneficiaries: (1) individuals younger than 65 years with a disability or end-stage kidney disease, (2) frail individuals, and (3) older individuals with major complex or multiple noncomplex chronic conditions...
April 2024: American Journal of Managed Care
https://read.qxmd.com/read/38601204/global-regional-and-national-burden-of-chronic-kidney-disease-attributable-to-high-fasting-plasma-glucose-from-1990-to-2019-a-systematic-analysis-from-the-global-burden-of-disease-study-2019
#7
JOURNAL ARTICLE
Huizhi Wei, Jinhong Ren, Rui Li, Xiaoming Qi, Fan Yang, Qingshan Li
PURPOSE: Given the rising prevalence of high fasting plasma glucose (HFPG) over the past three decades, it is crucial to assess its global, national, and regional impact on chronic kidney disease (CKD). This study aims to investigate the burden of CKD attributed to HFPG and its distribution across various levels. METHODS AND MATERIALS: The data for this research was sourced from the Global Burden of Diseases Study 2019. To estimate the burden of CKD attributed to HFPG, we utilized DisMod-MR 2...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38594299/mitochondrial-targeted-catalase-improves-muscle-strength-following-arteriovenous-fistula-creation-in-mice-with-chronic-kidney-disease
#8
JOURNAL ARTICLE
Kyoungrae Kim, Brian Fazzone, Tomas A Cort, Eric M Kunz, Samuel Alvarez, Jack Moerschel, Victoria R Palzkill, Gengfu Dong, Erik M Anderson, Kerri A O'Malley, Scott A Berceli, Terence E Ryan, Salvatore T Scali
Hand dysfunction is a common observation after arteriovenous fistula (AVF) creation for hemodialysis access and has a variable clinical phenotype; however, the underlying mechanism responsible is unclear. Grip strength changes are a common metric used to assess AVF-associated hand disability but has previously been found to poorly correlate with the hemodynamic perturbations post-AVF placement implicating other tissue-level factors as drivers of hand outcomes. In this study, we sought to test if expression of a mitochondrial targeted catalase (mCAT) in skeletal muscle could reduce AVF-related limb dysfunction in mice with chronic kidney disease (CKD)...
April 9, 2024: Scientific Reports
https://read.qxmd.com/read/38557506/status-of-serum-magnesium-serum-zinc-and-c-reactive-protein-in-hospitalized-patients-with-chronic-kidney-disease-in-mymensingh-locality
#9
JOURNAL ARTICLE
N H Nira, M R Hoque, S R Khan, M Ferdausee, F R Momo, R Ara
Chronic Kidney Disease (CKD) is an important public health issue, with a leading cause of death and disability around the world. This cross-sectional study was conducted from January 2021 to December 2021 in the department of Biochemistry in Mymensingh Medical College in cooperation with the Department of Nephrology, Mymensingh Medical College Hospital, Mymensingh, Bangladesh. The study was carried out to evaluate the status of serum magnesium, zinc and CRP in patients with CKD not on dialysis for monitoring the disease progression...
April 2024: Mymensingh Medical Journal: MMJ
https://read.qxmd.com/read/38541742/chronic-kidney-disease-with-mineral-bone-disorder-and-vascular-calcification-an-overview
#10
REVIEW
Carmine Izzo, Carmine Secondulfo, Giancarlo Bilancio, Valeria Visco, Nicola Virtuoso, Serena Migliarino, Michele Ciccarelli, Paola Di Pietro, Lucia La Mura, Antonio Damato, Albino Carrizzo, Carmine Vecchione
Chronic kidney disease (CKD) is a global health issue with a rising prevalence, affecting 697.5 million people worldwide. It imposes a substantial burden, contributing to 35.8 million disability-adjusted life years (DALYs) and 1.2 million deaths in 2017. The mortality rate for CKD has increased by 41.5% between 1990 and 2017, positioning it as a significant cause of global mortality. CKD is associated with diverse health complications, impacting cardiovascular, neurological, nutritional, and endocrine aspects...
March 21, 2024: Life
https://read.qxmd.com/read/38536785/work-disability-and-employment-status-among-advanced-chronic-kidney-disease-patients
#11
JOURNAL ARTICLE
Shing Shen Bay, Lydia Kamaruzaman, Rozita Mohd, Shamsul Azhar Shah
INTRODUCTION: Chronic kidney disease (CKD) is a major public health issue with significant socioeconomic impacts. In Malaysia, the prevalence of CKD in 2018 was 15%. Complications of CKD such as anaemia, mineral bone disease, and infections led to frequent hospitalizations resulting in work disability and unemployment. To date, there is no data of employment status of CKD patients in Malaysia. METHODS: A cross-sectional study of patients with advanced CKD (stage 4 and 5 non-dialysis) treated in our centre...
2024: PloS One
https://read.qxmd.com/read/38529465/a-case-report-of-neuro-beh%C3%A3-et-syndrome-frequent-neurological-manifestations-concurrent-with-life-threatening-illnesses
#12
Omar Ballut, Mayas M Almahi, Banan S Alghamdi, Najla K Alzahrani, Maali A Alghamdi
​​​​Behçet disease (BD) is a recurrent, multisystemic autoimmune vasculitis that affects both small and large vessels. A combination of neurological signs and symptoms in BD is called neuro-Behçet syndrome (NBS). We present the case of a 31-year-old male diagnosed with chronic progressive NBS who presented with multiple relapsing episodes concurrent with infective endocarditis due to intravenous drug abuse, drug-induced hepatitis, acute kidney injury, and septic shock that is not related to BD...
February 2024: Curēus
https://read.qxmd.com/read/38512378/temporal-trends-in-prevalence-and-disability-of-chronic-kidney-disease-caused-by-specific-etiologies-an-analysis-of-the-global-burden-of-disease-study-2019
#13
JOURNAL ARTICLE
Xin Qing, Junyi Jiang, Chunlei Yuan, Kunke Xie, Ke Wang
BACKGROUND: The prevalence of disability in CKD is high. In this context the aim of the present study was to assess the  temporal trends of prevalence and disability progression for chronic kidney disease (CKD) caused by specific etiologies. METHODS: Using data from the Global Burden of Diseases Study (GBD) 2019, we examined the age-standardized rates of CKD prevalence and disability-adjusted life-years for different etiologies, including Type 1/2 diabetes mellitus (T1DM/T2DM), glomerulonephritis, and hypertension...
March 21, 2024: Journal of Nephrology
https://read.qxmd.com/read/38478491/cost-effectiveness-of-screening-for-chronic-kidney-disease-using-a-cumulative-egfr-based-statistic
#14
JOURNAL ARTICLE
Reyhaneh Zafarnejad, Qiushi Chen, Paul M Griffin
OBJECTIVES: Routine screening for chronic kidney disease (CKD) could enable timely interventions to slow down disease progression, but currently there are no clinical guidelines for screening. We aim to evaluate the cost-effectiveness of screening for CKD using a novel analytical tool based on a cumulative sum statistic of estimated glomerular filtration rate (CUSUMGFR). METHODS: We developed a microsimulation model that captured CKD disease progression, major complications, patients' awareness, and treatment adherence for a nationally representative synthetic cohort of age ≥ 30 years in the United States...
2024: PloS One
https://read.qxmd.com/read/38472620/renal-effects-of-glp-1-receptor-agonists-and-tirzepatide-in-individuals-with-type-2-diabetes-seeds-of-a-promising-future
#15
REVIEW
Irene Caruso, Francesco Giorgino
PURPOSE: Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management. The dual GIP/GLP-1 receptor agonist tirzepatide is among the furthest developed multi-agonists for diabetes care and has so far displayed promising nephroprotective effects. This review aims to summarize the evidence regarding the nephroprotective effects of glucagon-like peptide-1 receptor agonists (GLP-1RA) and tirzepatide and the putative mechanisms underlying the favorable renal profile of tirzepatide...
March 12, 2024: Endocrine
https://read.qxmd.com/read/38459571/patients-and-physicians-awareness-of-clinical-symptoms-and-disease-severity-in-tuberous-sclerosis-complex
#16
JOURNAL ARTICLE
Matthias Sauter, Lea Weber, Dominik Jung, Michael Weremko, Dorothea Bachmann, Michael Fischereder, Hagen Sjard Bachmann
Tuberous sclerosis complex (TSC) is a rare inherited disease with the potential to affect virtually every organ system. Clinical presentation is age- and partly sex-dependent and varies broadly with respect to disease manifestations including treatment-refractory epilepsy, intellectual disability and TSC-associated neuropsychiatric disorders, chronic kidney disease or progressive lung function decline. Given the complexity of this disease, multidisciplinary care in specialized TSC centres is recommended. We aimed to elucidate the state of knowledge of patients/caregivers and physicians on individual disease manifestations...
March 8, 2024: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/38455876/developing-international-classification-of-disease-code-definitions-for-the-study-of-enteric-infection-sequelae-in-canada
#17
JOURNAL ARTICLE
Eleni Galanis, Azita Goshtasebi, Yuen Wai Hung, Jonathan Chan, Douglas Matsell, Kristine Chapman, Gilaad Kaplan, David Patrick, Bei Yuan Zhang, Marsha Taylor, Dimitra Panagiotoglou, Shannon Majowicz
BACKGROUND: Enteric infections and their chronic sequelae are a major cause of disability and death. Despite the increasing use of administrative health data in measuring the burden of chronic diseases in the population, there is a lack of validated International Classification of Disease (ICD) code-based case definitions, particularly in the Canadian context. Our objective was to validate ICD code definitions for sequelae of enteric infections in Canada: acute kidney injury (AKI); hemolytic uremic syndrome (HUS); thrombotic thrombocytopenic purpura (TTP); Guillain-Barré syndrome/Miller-Fisher syndrome (GBS/MFS); chronic inflammatory demyelinating polyneuropathy (CIDP); ankylosing spondylitis (AS); reactive arthritis; anterior uveitis; Crohn's disease, ulcerative colitis, celiac disease, erythema nodosum (EN); neonatal listeriosis (NL); and Graves' disease (GD)...
August 1, 2023: Canada Communicable Disease Report
https://read.qxmd.com/read/38452996/achieving-consensus-severity-graded-definitions-of-fontan-associated-complications-to-characterize-fontan-circulatory-failure
#18
JOURNAL ARTICLE
Kurt R Schumacher, Ari Cedars, Kiona Allen, David Goldberg, Adrianna Batazzi, Garrett Reichle, Frank DiPaola, David Selewski, Melissa Cousino, David N Rosenthal
BACKGROUND: Fontan physiology leads to chronic changes in other organ systems that may affect long-term survival and the success of heart transplantation. Inadequate assessment and treatment of the extra-cardiac effects of Fontan may contribute to poor outcomes. Severity graded/ordinal consensus definitions of Fontan complications are lacking which limits understanding of how Fontan-specific morbidity affects patient outcomes. METHODS AND RESULTS: A panel of Fontan patient and physiology experts, including pediatric, adult congenital, heart failure, and critical care cardiology, and pediatric nephrology, hepatology and psychology, convened to develop definitions of Fontan complications...
March 5, 2024: Journal of Cardiac Failure
https://read.qxmd.com/read/38427291/the-interplay-between-dietary-choline-and-cardiometabolic-disorders-a-review-of-current-evidence
#19
REVIEW
Natalia G Vallianou, Dimitris Kounatidis, Sotiria Psallida, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela, Dimitrios Tsilingiris, Maria Dalamaga
PURPOSE OF REVIEW: Choline is an essential nutrient for human health and cellular homeostasis as it is necessary for the synthesis of lipid cell membranes, lipoproteins, and the synthesis of the neurotransmitter acetylcholine. The aim of this review is to analyze the beneficial effects of choline and its significance in cellular metabolism and various inflammatory pathways, such as the inflammasome. We will discuss the significance of dietary choline in cardiometabolic disorders, such as non-alcoholic fatty liver disease (NAFLD), cardiovascular disease (CVD), and chronic kidney disease (CKD) as well as in cognitive function and associated neuropsychiatric disorders...
March 1, 2024: Current Nutrition Reports
https://read.qxmd.com/read/38418541/measures-of-type-2-diabetes-burden-in-italy-assessed-using-the-amd-dataset-over-a-twelve-year-span-across-the-great-recession
#20
JOURNAL ARTICLE
Cristiana Abbafati, Luciano Nieddu, Lorenzo Monasta
Patients with Type 2 Diabetes Mellitus (T2DM) are rapidly increasing in Italy due to aging, preventable risk factors, and worsening socioeconomic context. T2DM and its sequelae take a heavy toll on healthcare systems and the economy, given costly management, difficulties in coping with everyday life, and decreasing patient/worker productivity. Considering long life expectancy in Italy and a decreasing mortality rate due to T2DM, this study aims to calculate the years lived with disability (YLDs) of T2DM and its sequelae grouped into three categories: Neuropathy, Chronic Kidney Disease and No Complications, taking into consideration sex, year, and geographical location...
February 28, 2024: Scientific Reports
keyword
keyword
23167
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.